Look for CRISPR/Cas9 to Treat Eye Diseases First, Scientists Say

Feb 04, 2016

|

This is the fourth article in an in-depth series on the impact of CRISPR/Cas9 genome editing technology on basic and clinical research, the biotechnology industry, and the world at large. The first installment, on the development of the CRISPR toolkit, can be found here.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Holden Thorp to Take Over at Science

Holden Thorp is to be the new editor-in-chief of Science and its related journals.

Fewer Fish in the River

A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.

Ancient DNA Lab Head Suspended During Workplace Culture Review

Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.

PNAS Studies Describe Adipocyte Subtypes, Plant Expressome Analysis, More

In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.

Featured White Papers

Automated Genomic DNA Extraction from Large Volume Whole Blood

RNAGEM - mRNA Profiles as Close to Biological Reality as Possible

Application Note: How to Pipette PCR Master Mix for Increased Accuracy in qPCR Results

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Aug

28

Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Menu